Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1360001
European Journal of Endocrinology, Vol 136, Issue 1, 1-7
Copyright © 1997 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hofbauer, L. C
Right arrow Articles by Heufelder, A. E
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hofbauer, L. C
Right arrow Articles by Heufelder, A. E

Coagulation disorders in thyroid diseases

Lorenz C Hofbauer and Armin E Heufelder

Introduction: Various abnormalities of coagulation occur in patients with thyroid diseases, and may range from subclinical laboratory abnormalities to clinically significant disturbances of coagulation and, rarely, major hemorrhage or thromboembolism (1). Patients with hypothyroidism are at particular risk of hemorrhage (2). In contrast, patients with hyperthyroidism display a tendency to develop thromboembolic complications, with major embolism accounting for up to 18% of deaths in patients dying from thyrotoxicosis (3). Pathogenesis of coagulopathies associated with thyroid diseases may include direct and indirect effects of excess or deficiency of thyroid hormones on platelet maturation and function, on synthesis and action of coagulation factors, and on altered blood viscosity (4). In addition, coagulopathies in patients with autoimmune thyroid diseases may be related to an individual's underlying susceptibility to develop autoimmune diseases. In this review, we will summarize the spectrum of coagulation disorders associated with thyroid diseases, discuss recent progress in the understanding of




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Homoncik, A. Gessl, A. Ferlitsch, B. Jilma, and H. Vierhapper
Altered Platelet Plug Formation in Hyperthyroidism and Hypothyroidism
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3006 - 3012.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Squizzato, E. Romualdi, H. R. Buller, and V. E. A. Gerdes
Thyroid Dysfunction and Effects on Coagulation and Fibrinolysis: A Systematic Review
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2415 - 2420.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
S. Gullu, H. Sav, and N. Kamel
Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism
Eur. J. Endocrinol., March 1, 2005; 152(3): 355 - 361.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Chadarevian, E. Bruckert, L. Leenhardt, P. Giral, A. Ankri, and G. Turpin
Components of the Fibrinolytic System Are Differently Altered in Moderate and Severe Hypothyroidism
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 732 - 737.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 European Society of Endocrinology.